diclofenac has been researched along with 4-aminopyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Rosas, R; Vidal-Cantú, GC | 1 |
| Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Rosas, R; Torres-López, JE; Vidal-Cantú, GC | 1 |
| Fujimoto, S; Kunimatsu, M; Mori, M; Tsushima, H | 1 |
| Duan, KZ; Mei, YA; Xu, Q; Zhang, XM; Zhang, YQ; Zhao, ZQ | 1 |
4 other study(ies) available for diclofenac and 4-aminopyridine
| Article | Year |
|---|---|
Evidence for a new mechanism of action of diclofenac: activation of K+ channels.
Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP-Binding Cassette Transporters; Behavior, Animal; Diclofenac; Female; Formaldehyde; Glyburide; Hypoglycemic Agents; KATP Channels; Pain Measurement; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar | 2001 |
Pharmacological evidence for the activation of K(+) channels by diclofenac.
Topics: 4-Aminopyridine; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; Behavior, Animal; Charybdotoxin; Diclofenac; Dose-Response Relationship, Drug; Female; Formaldehyde; Glyburide; Hindlimb; Morphine; Pain; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Tetraethylammonium; Tolbutamide | 2002 |
Capsaicin-induced, capsazepine-insensitive relaxation of the guinea-pig ileum.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Apamin; Barium; Benzopyrans; Caffeine; Calcitonin Gene-Related Peptide; Calcium; Capsaicin; Charybdotoxin; Diclofenac; Dimethyl Sulfoxide; Diterpenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanethidine; Guinea Pigs; Ileum; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Muscle Relaxation; Muscle, Smooth; Myosin Light Chains; Nitroarginine; Papaverine; Peptide Fragments; Phosphodiesterase Inhibitors; Phosphorylation; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Protein Serine-Threonine Kinases; Pyrazoles; Receptor, Cannabinoid, CB1; rho-Associated Kinases; Tetraethylammonium; Vasodilator Agents | 2006 |
Targeting A-type K(+) channels in primary sensory neurons for bone cancer pain in a rat model.
Topics: 4-Aminopyridine; Activating Transcription Factor 3; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Biophysics; Bone and Bones; Bone Neoplasms; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Extremities; Female; Functional Laterality; Ganglia, Spinal; Glycoproteins; Hyperalgesia; Lectins; Membrane Potentials; Nerve Tissue Proteins; Pain; Pain Threshold; Patch-Clamp Techniques; Physical Stimulation; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Radiography; Rats; Rats, Wistar; RNA, Small Interfering; Scorpion Venoms; Sensory Receptor Cells; Time Factors; Versicans | 2012 |